Search - tctmd.com

Displaying 861 - 880 of 1207

Sort: Relevancy | Date

News Daily News

Postapproval Study Confirms Safety, Efficacy of Transcatheter Pulmonary Valve in Real World

L.A. McKeown

December 04, 2014

News Industry News

New Data From EVOLVE Clinical Program Demonstrate SYNERGY™ Bioabsorbable Polymer Stent Meets Key Performance Endpoints

November 18, 2014

News Industry News

Medtronic Adds to Endurant 'AAA' Stent Graft System

November 11, 2014

News Daily News

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

Yael L. Maxwell

November 06, 2014

News Daily News

Dabigatran Carries Higher Risk of Major Bleeds, Lower Risk of Intracranial Hemorrhage

Todd Neale

November 06, 2014

News Industry News

Medtronic Drug-Coated Balloon for Peripheral Artery Disease Also Benefits Patients with Diabetes in Landmark Study

November 03, 2014

News Daily News

Los BRF son Mejores en Lesiones De Novo que en Lesiones Femoropoplíteas Reestenóticas

Caitlin E. Cox

October 24, 2014

News Daily News

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Caitlin E. Cox

October 24, 2014

News Industry News

Boston Scientific Initiates Study Of Promus PREMIER™ Coronary Stent System In Underserved Patient Populations

October 20, 2014

News Daily News

得到的FDA专家组支持率低，Watchman可能为时不多了

L.A. McKeown

October 16, 2014

News Daily News

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

L.A. McKeown

October 16, 2014

News Industry News

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

October 10, 2014

Presentation TCT 2014

The Emphatic Case for OPCs NOW for New DES Approval in the United States!

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Laura Mauri

September 16, 2014

Presentation TCT 2014

Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines

Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Kenya Brothers

September 16, 2014

Presentation TCT 2014

Regulatory Approval Pathways for Novel vs Iterative TAVR Devices: Back to the Future?

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Nicole Ibrahim

September 16, 2014

News Conference News TCT 2014

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

September 16, 2014

News Industry News

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

September 16, 2014

News Conference News TCT 2014

Affordable Care Act-Related Changes Hold Promise for Future of Device Innovation, Physician Payments

September 16, 2014

News Industry News

St. Jude Medical Announces Launch of OPTIS Integrated System

September 15, 2014

Presentation TCT 2014

FDA Approval Process: PMA vs CE Mark

Presenter: Sigmund Silber

September 13, 2014

Advertisement

Postapproval Study Confirms Safety, Efficacy of Transcatheter Pulmonary Valve in Real World

New Data From EVOLVE Clinical Program Demonstrate SYNERGY™ Bioabsorbable Polymer Stent Meets Key Performance Endpoints

Medtronic Adds to Endurant 'AAA' Stent Graft System

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

Dabigatran Carries Higher Risk of Major Bleeds, Lower Risk of Intracranial Hemorrhage

Medtronic Drug-Coated Balloon for Peripheral Artery Disease Also Benefits Patients with Diabetes in Landmark Study

Los BRF son Mejores en Lesiones De Novo que en Lesiones Femoropoplíteas Reestenóticas

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Boston Scientific Initiates Study Of Promus PREMIER™ Coronary Stent System In Underserved Patient Populations

得到的FDA专家组支持率低，Watchman可能为时不多了

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

The Emphatic Case for OPCs NOW for New DES Approval in the United States!

Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines

Regulatory Approval Pathways for Novel vs Iterative TAVR Devices: Back to the Future?

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

Affordable Care Act-Related Changes Hold Promise for Future of Device Innovation, Physician Payments

St. Jude Medical Announces Launch of OPTIS Integrated System

FDA Approval Process: PMA vs CE Mark

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content